CDKN2A and neoplasm: In these tumours, the HIPPO-TAZ/YAP pathway is hyperactivated, PRC2 is inactivated, and there is a complete loss of the H3K27 trimethylation mark along with inactivation of the Ink4a/Arf locus promoting unrestricted proliferation and malignant transformation [202–206].